Translational Medicine Reports is a peer-reviewed international journal publishing articles in the field of molecular biology, biochemistry and nanotechnology applied to the treatment of chronic-degenerative diseases including diabetes, cancer, neurological, cardiovascular and metabolic disorders. Aim of the Journal is to contribute to bridging the gap between basic research and clinical applications from an interdisciplinary perspective. Translational Medicine Reports addresses researchers and managers in academia, biotechnology and pharmaceutical industry researchers, physician scientists, etc. Original Articles with interdisciplinary topics, Reviews, Editorials, From Bench-to-Bedside Articles, Conference Proceedings, and Letters to the Editor are welcome. Every article published in the Journal will be peer-reviewed by experts in the field and selected by members of the Editorial Board.
The journal is completely free: no charge for publication, as it is supported by private funds.
Dear Authors, a large number of reviewers in Europe and particularly in Italy, are clinicians: their commitment in the current public health emergency is aimed at helping and treating people. Our greatest thanks go to them.
We renew our commitment to guarantee you the peer-review process of your papers submitted to the Journal as soon as possible and we are confident we have your understanding for possible small delays.